| Cost-effectiveness analysis of dapagliflozin in the management of heart failure with reduced ejection fraction (HFrEF): a systematic review G Mohammadnezhad, B Azadmehr, M Mirheidari, N Yousefi Cost Effectiveness and Resource Allocation 20 (1), 62, 2022 | 4 | 2022 |
| Lenvatinib in the treatment of unresectable hepatocellular carcinoma: a systematic review of economic evaluations G Mohammadnezhad, H Noqani, P Rostamian, M Sattarpour, J Arabloo European Journal of Clinical Pharmacology 79 (7), 885-895, 2023 | 3 | 2023 |
| Community Pharmacists’ Practice Regarding Vitamin D Products: A Simulated Client Method G Mohammadnezhad, M Sattarpour, M Azadi Kakavand, H Esmaily Journal of Patient Safety & Quality Improvement 11 (2), 73-80, 2023 | 2 | 2023 |
| A Cost-effectiveness Analysis of Adding Cetuximab to the First-line Treatment of Metastatic Colorectal Carcinoma in Iran; Considering Genetic Screening for Precision Medicine N Yousefi, A Salimi, G Mohammadnezhad, S Taheri, F Peiravian Journal of Gastrointestinal Cancer 54 (4), 1212-1219, 2023 | 1 | 2023 |
| Comparing the efficacy of three methods of permethrin application in pediculosis capitis: A randomized clinical trial N Ghalandari, A Edalatkhah Tatafi, G Mohammadnezhad, M Nasimi, ... Journal of Cosmetic Dermatology 22 (11), 3065-3071, 2023 | 1 | 2023 |
| Association between Knowledge and Vitamin D Serum Level among Vitamin D Consumers in Tehran, Iran G Mohammadnezhad, M Talebi, H Esmaily International Journal of Nutrition Sciences 8 (3), 158-165, 2023 | 1 | 2023 |
| A Cost-effectiveness Analysis of Adding Cetuximab to the First-line Treatment of Metastatic Colorectal Carcinoma in Iran; Considering Genetic Screening for Precision Medicine N Youse, A Salimi, G Mohammadnezhad, S Taheri, F Peiravian J Gastrointest Cancer [Internet], 1-8, 2023 | 1 | 2023 |
| Budget impact analysis of breast cancer medications: a systematic review G Mohammadnezhad, M Sattarpour, N Moradi Journal of Pharmaceutical Policy and Practice 15 (1), 105, 2022 | 1 | 2022 |
| Cost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review G Mohammadnezhad, B Azadmehr, N Yousefi Expert Review of Pharmacoeconomics & Outcomes Research 22 (8), 1187-1198, 2022 | 1 | 2022 |
| Development of Thalassemia Medication Questionnaire (TMQ): An Instrument for Measuring Major Thalassemia Patients’ Knowledge and Practice Regarding their Medications A Azarkeivan, G Mohammadnezhad, H Esmaily Journal of Pharmaceutical Care, 2022 | 1 | 2022 |
| Awareness and Practical Evaluation of Correct Use of Iron Chelators; A Study to Track the Ambiguities of Thalassemia Patients on Their Medications in Iran MS Mousavi, G Mohammadnezhad, F Yaghmaei, A Azarkeivan, ... | | 2024 |
| Atezolizumab and Bevacizumab Targeted-Therapy in Advanced Hepatocellular Carcinoma: A Systematic Review of Cost-effectiveness Analyses G Mohammadnezhad, H Esmaily, M Talebi, M Jafari Journal of Gastrointestinal Cancer, 1-13, 2024 | | 2024 |
| The Impact of Utilizing Electronic Information Databases on Evidence-Based Practice Among Iranian Pharmacists: A Simulated-Based Survey. H Pourbala, G Mohammadnezhad, H Esmaily | | 2024 |
| Drug-Related Problems and Clinical Pharmacist-Led Medication Therapy Management; Three-Year Survey in an Educational Pharmacotherapy Clinic N Valitabar, H Esmaily, M Sistanizad, S Roshanzamiri, A Farrokhian, ... | | 2024 |
| Developing a Discrete Choice Experiment Instrument for Evaluating Patients’ Preferences in Precision Oncology ZK Majd, N Yousefi, M Peikanpour, M Sistanizad, G Mohammadnezhad, ... Iranian Journal of Pharmaceutical Research, 2023 | | 2023 |
| Cost-Utility Analysis of Mirabegron Compared to Solifenacin in the Treatment of Overactive Bladder (OAB) in Iran ZK Majd, G Mohammadnezhad, S Taheri, N Yousefi Iranian Journal of Pharmaceutical Research, 2023 | | 2023 |
| Is Community Pharmacies’ Personnel Well-Oriented about Cosmeceuticals? A Cross-sectional Survey and Costumer Simulation N Yousefi, H Noqani, G Mohammadnezhad, MJ Foroughi, F Peiravian | | 2023 |
| Pharmacist Intervention in Controlling Symptoms with Common Upper Respiratory Disease G Mohammadnezhad, M Jafari, H Esmaily Iranian Journal of Culture and Health Promotion 7 (1), 68-74, 2023 | | 2023 |
| Atezolizumab and Bevacizumab Combination in Advanced Hepatocellular Carcinoma; A Systematic Review of Economic Evaluations G Mohammadnezhad, H Esmaily, M Talebi, M Jafari | | 2023 |
| An adapted model of cost-related medication nonadherence among older adult patients with chronic diseases: an Iranian qualitative study S Rezaei, M Peikanpour, L Zarei, G Mohammadnezhad, J Salamzadeh BMC geriatrics 23 (1), 208, 2023 | | 2023 |
Hadi EsmailyAssistant Professor Of Clinical Pharmacy, School Of Pharmacy, Shahid Beheshti University Of MedicalVerified email at sbmu.ac.ir
